Stock screenerAll disclosures →
EDGAR →
NAGE
Conviction 20HealthcareScan · Mon, Aug 10, 2026NAGE$3.05-2.24%
ResistanceSupportVol 14Vol MA14 906.16K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price3.05
Change-2.24%
Gap-0.80%
Rel volume2.37×
Avg volume854.02K
Avg $ vol2.78M
SMA 203.29
SMA 503.38
SMA 2005.04
Price vs 50-9.80%
Price vs 200-39.50%
MA stackbearish
50/200 cross—
Supertrenddown · 3.56
RSI (14)41
MACD hist-0.02
MACD crossbear · 3d
Stoch %K / %D24 / 26
ADX (14)19
+DI / −DI20 / 31
RSI divergence—
MACD divergence—
ATR %+5.99%
ADR %4.95%
52w high10.26
52w low2.96
From 52w high-70.27%
Above 52w low+3.04%
New 52w highNo
SqueezeOff
Bollinger width19.00%
%B0.12
Donchian pos23.84%
Donchian high3.63
Donchian low2.87
AVWAP (52w high)5.94
vs AVWAP high-48.62%
AVWAP (52w low)3.03
vs AVWAP low+0.64%
OBV trendFlat
Chaikin MF (20)0.06
Today vs 20d2.37×
Avg vol (14d)906.16K
Avg vol (20d)854.02K
Avg $ vol (20d)2.78M
Market cap241.33M
RS 3m (vs SPY)-31.23%
RS 6m (vs SPY)-53.30%
RS line new highNo
Trend template0/8
Technical rank12.4
1 week-13.60%
1 month-10.03%
3 months-26.86%
6 months-41.35%
1 year-68.26%
YTD-51.20%
P/E13.88
P/B2.92
P/S1.86
P/FCF18.91
EPS0.2000
Div yield—
ROE21.06%
ROA16.31%
Debt/Eq0.00
Current6.50
EV/EBITDA10.50
Gross margin64.28%
Net margin13.43%
Rev growth29.95%
EPS growth103.30%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value177.23M
Revenue29.79M
Net income963K
Gross profit19.31M
Free cash flow12.76M
IndustryMEDICINAL CHEMICALS & BOTANICAL PRODUCTS
ExchangeNasdaq
Shares out79.64M
Employees117
ListedTue, Jun 24, 2008
Free float48.42M
Float %60.5%
Short interest4.79M
Days to cover6.5d
Short volume40.8%
Squeeze score60 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction20 / 100
Pattern quality—
Tech rank12.4 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance3.63
Support2.99
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in NAGE
No recent disclosed trades by Congress in NAGE. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in NAGE · 4 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Fried Robert N Chief Executive Officer · Common Stock · 2026-06-30 | Grant | 1.11K | $3K | 2026-06-30 | 2026-07-08 |
Lopez Carlos Luis SVP, General Counsel · Common Stock · 2026-06-30 | Grant | 2.31K | $6K | 2026-06-30 | 2026-07-08 |
Pamir Ozan Chief Financial Officer · Common Stock · 2026-06-30 | Grant | 4.25K | $12K | 2026-06-30 | 2026-07-08 |
Cohen Ann Director · Stock Option (right to buy) · 2026-06-24 | Grant | 31.75K | — | 2026-06-24 | 2026-06-26 |
SEC filings
EDGAR filings in NAGE · 6 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.